Two short-peptide bioregulators from the same St. Petersburg lineage, studied in different models. Telomere biology meets neuronal oxidative stress, all of it preclinical.
Two copper tripeptides differing by a single N-terminal residue — and by decades of evidence. A sober, research-use-only reading of what the literature on GHK-Cu and AHK-Cu actually shows.
Two reference secretagogues, two receptors. A research-use comparison of their chemistry, mechanisms, and the honest state of the published evidence.
Two compounds, one pathway, one enzymatic step apart. A precise, evidence-honest look at when researchers reach for the precursor versus the coenzyme.
Two synthetic heptapeptides from the same Soviet-era programme, built on different parent molecules and studied along sharply divergent mechanistic lines.
Two molecules lumped together as metabolic small molecules that share no target, no mechanism and no research question, set side by side.
Two compounds shelved side by side in metabolic catalogues turn out to share almost nothing at the molecular level — one switches an enzyme off, the other switches a receptor program on.
Two peptides forever paired in regenerative literature, yet chemically and mechanistically unrelated. What the preclinical record actually says, and why the choice is a research question, not a ranking.
Cookies
We use strictly necessary cookies to run the store. With your consent we also use analytics (order attribution) and marketing (Omnisend) cookies. Read our Cookie Policy.
